Multicomponent solid forms of the uric acid reabsorption inhibitor lesinurad and cocrystal polymorphs with urea: DFT simulation and solubility studyстатья
Статья опубликована в высокорейтинговом журнале
Информация о цитировании статьи получена из
Web of Science,
Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 18 сентября 2019 г.
Аннотация:Lesinurad (systematic name: 2-{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-
1,2,4-triazol-3-yl]sulfanyl}acetic acid, C17H14BrN3O2S) is a selective uric acid
reabsorption inhibitor related to gout, which exhibits poor aqueous solubility.
High-throughput solid-form screening was performed to screen for new solid
forms with improved pharmaceutically relevant properties. During polymorph
screening, we obtained two solvates with methanol (CH3OH) and ethanol
(C2H5OH). Binary systems with caffeine (systematic name: 3,7-dihydro-1,3,7-
trimethyl-1H-purine-2,6-dione, C8H10N4O2) and nicotinamide (C6H6N2O),
polymorphs with urea (CH4N2O) and eutectics with similar drugs, like
allopurinol and febuxostat, were prepared using the crystal engineering
approach. All these novel solid forms were confirmed by XRD, DSC and FT–
IR. The crystal structures were solved by single-crystal and powder X-ray
diffraction. The crystal structures indicate that the lesinurad molecule is highly
flexible and the triazole moiety, along with the rotatable thioacetic acid (side
chain) and cyclopropane ring, is almost perpendicular to the planar naphthalene
moiety. The carboxylic acid–triazole heterosynthon in the drug is interrupted by
the presence of methanol and ethanol molecules in their crystal structures and
forms intermolecular macrocyclic rings. The caffeine cocrystal maintains the
consistency of the acid–triazole heterosynthons as in the drug and, in addition,
they are bound by several auxiliary interactions. In the binary system of
nicotinamide and urea, the acid–triazole heterosynthon is replaced by an acid–
amide synthon. Among the urea cocrystal polymorphs, Form I (P1, 1:1) consists
of an acid–amide (urea) heterodimer, whereas in Form II (P21/c, 2:2), both acid–
amide heterosynthons and urea–urea dimers co-exist. Density functional theory
(DFT) calculations further support the experimentally observed synthon
hierarchies in the cocrystals. Aqueous solubility experiments of lesinurad and
its binary solids in pH 5 acetate buffer medium indicate the apparent solubility
order lesinurad–urea Form I (43-fold) > lesinurad–caffeine (20-fold) >
lesinurad–allopurinol (12-fold) ’ lesinurad–nicotinamide (11-fold) > lesinurad,
and this order is correlated with the crystal structures.